title: HIV-1 neutralization directed to epitopes other than linear V3 determinants.
authors.affiliation: Chiron Corporation, Emeryville, CA 94608-2916.
authors.forename: K S
authors.initials: KS
authors.lastname: Steimer
authors.forename: P J
authors.initials: PJ
authors.lastname: Klasse
authors.forename: J A
authors.initials: JA
authors.lastname: McKeating
mesh_terms: D016915:AIDS Vaccines; D000911:Antibodies, Monoclonal; D000939:Epitopes; D014644:Genetic Variation; D015483:HIV Antibodies; D015699:HIV Envelope Protein gp120 / Q000276:immunology*; D015497:HIV-1 / Q000276:immunology*; D010446:Peptide Fragments / Q000276:immunology*; D015728:Receptors, HIV / Q000276:immunology
chemical_list: D016915:AIDS Vaccines; D000911:Antibodies, Monoclonal; D000939:Epitopes; D015483:HIV Antibodies; D015699:HIV Envelope Protein gp120; C059762:HIV envelope protein gp120 (305-321); D010446:Peptide Fragments; D015728:Receptors, HIV